resolver

Ghoos, Y.F., Maes, B.D., Geypens, B.J., Mys, G., Hiele, M.I., Rutgeerts, P.J.,
Vantrappen, G. (1993). Measurement of gastric emptying rate of solids by means of
a carbon-labeled octanoic acid breath test. Gastroenterology 104, 1640-1647
Glue, P. (1999). The clinical pharmacology of ribavirin. Semin Liver Dis. 19, 17-24
Göke, B., Fehmann, H.C., Schirra, J., Hareter, A., Göke, R. (1997). The intestinal
hormone glucagon-like peptide 1 (GLP-1): from experiment to the clinic. Z
Gastroenterol. 35, 285-294
Gottrand, F., Michaud, L., Guimber, D., Ategbo, S., Dubar, G., Turck, D., Farriaux,
J.P. (1996). Influence of recombinant interferon alpha on nutritional status and
growth pattern in children with chronic viral hepatitis. Eur J Pediatr. 155, 1031-1034
Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, Murthy KK,
Rice CM, Walker CM. (2003). HCV persistence and immune evasion in the absence
of memory T cell help. Science 302, 659-662.
Grandt, D., Schimiczek, M., Beglinger, C., Layer, P., Goebell, H., Eysselein, V.E.,
Reeve, J.R. (1994). Two molecular forms of peptide YY (PYY) are abundant in
human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and
PYY 3-36. Regul Pept. 51, 151-159
Hadziyannis, S.J., Sette, H., Morgan, T.R., Balan, V., Diago, M., Marcellin, P.,
Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., Zeuzem, S., Pockros,
P.J., Lin, A., Ackrill, A.M., PEGASYS International Study Group. (2004).
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a
randomized study of treatment duration and ribavirin dose.
Ann Intern Med. 140, 346-355
Harper, A.A., Raper, H.S. (1943). Pancreozymin, a stimulant of the secretion of
pancreatic enzymes in the extracts of the small intestine. J Physiol. 102, 115-125
75